US Patent Issued to Celgene on July 1 for "Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same" (New Jersey Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,346, issued on July 1, was assigned to Celgene Corp. (Summit, N.J.).

"Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same" was invented by Benjamin M. Cohen (Cranford, N.J.), John F. Traverse (Lebanon, N.J.), Jean Xu (Warren, N.J.) and Ying Li (Millburn, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Salts and solid forms of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a stereoisomer thereof, are disclosed. Compositions comprising and methos of using the salts and solid forms are also disclos...